Merkel Cell Carcinoma and Lymphoma

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is deadlier than melanoma, is known to metastasize quickly, has a high recurrence rate, and affects men more than women.

MCC is most prevalent in areas of the skin exposed to the sun. In fact the head and neck are the most commonly reported areas. Although it can develop a number of ways, the most common manner is by way of a polyomavirus. It doesn’t much matter though the origin of the tumor, this is a highly malignant and aggressive cancer.

MCC and Lymphoma

The reader might be wondering if MCC is considered a cutaneous lymphoma of T-cell origin or even B-cell origin; after all, this is a lymphoma site. MCC is not a lymphoma. But it does have a strange association with blood cancers.

Specifically, while the average age for most people to develop MCC is 72, the age is much lower in people who are immunocompromised. People who are organ transplant recipients are at a 10-fold higher risk of developing MCC; people who have been diagnosed with HIV/AIDS are at a 13-fold higher risk, and finally, those patients with chronic lymphocytic leukemia (CLL) are at a 30-fold increased risk. To wit, these people tend to develop MCC about 20 years sooner than the general population.

It is not known precisely what the connection or association is. However, one possible link might be found in the fact that both CLL and MCC have been closely associated with so-called P53 genetic mutations. Since s

o many cases are caused by the Merkel cell polyomavirus, it’s possible that it is merely an opportunistic infection.

MCC Treatment

Whatever the case, the fact of the matter is that a diagnosis of MCC is a very serious matter, whether or not the patient has CLL or SLL. The disease lacks clinical symptoms meaning that it is often not found until it has spread to distant parts of the body.

Most recommendations include surgical excision of the skin tumor, along with radiotherapy and maybe chemotherapy. However, survival rates are currently rather low and people with CLL/SLL should have any suspicious skin sores or lesions seen by their physician as soon as possible.

[The accompanying photo, from Wikipedia, shows Merkel cell carcinoma on the individual's left arm.]

Source

Hasan S et al. The role of postoperative radiation and chemoradiation in Merkel cell carcinoma Front. Oncol. 14 Nov 2013.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

In a large trial of older, newly diagnosed patients with chronic lymphocytic leukemia (CLL),...

Sitemap